ICU and You · Journal Club · Number 99
A nine-year-old with mycoplasma, and three complications nobody expects from a mild organism
Kim SY, Kim JD, Park M, Kim KW, Sohn MH. Disproportionate respiratory deterioration in severe Mycoplasma pneumoniae pneumonia caused by airway obstruction and thromboembolism: a case report. Archives of Pediatric Critical Care 2026;4(1):17–22.
Read the paperOpen access under CC BY-NC 4.0. Worth opening for the images alone: six serial chest films, the CT showing the filling defect, and the bronchoscopic view before and after the cast came out.
Because they are the news. Not the formal, ceremonial version of reading — the daily kind. The journals are our news pages, our opinion columns, our form guide and our sports results. People who would not dream of going a week without knowing what happened in the world will go a year without knowing what happened in their own specialty, and then wonder why the registrar knows something they do not.
It does not have to be a session. You do not need an hour, a highlighter or a plan. Read the abstracts. Skim the contents page of one journal while the kettle boils. Open the one paper in ten that looks interesting and abandon it at paragraph three if it is not. Nobody is marking this.
What matters is staying curious rather than staying current — nobody is current, and the people who claim to be are reading less than they say. What you are actually maintaining is the habit of noticing: that a question is open, that a practice has shifted, that somebody has published the thing you were arguing about last month.
And then do the part that makes it stick. Mention it on a ward round. Argue about it with somebody who disagrees. Ask what the study could not have shown. A paper read alone is half a paper.
Publish or perish is the line we all know. The quieter one is this: absorb it, or lose your edge.
A previously well nine-year-old, five days of high fever and a productive cough, already treated for three days at another hospital for a left lower lobe pneumonia and getting worse. Nasopharyngeal PCR positive for Mycoplasma pneumoniae, viral panel negative.
On arrival he was lethargic but alert, febrile at 39.3, mildly tachycardic, and saturating 94 per cent in air. His white count was normal — 8,270 — with a C-reactive protein of 36.8. Nothing about the blood picture suggested what was coming.
Over the next three days the left hemithorax whited out. A drain yielded 700 mL of straw-coloured exudate: protein 4,400 mg/dL, LDH 3,300, ninety-three per cent mononuclear cells, and a preserved pH and glucose with negative cultures. That combination matters, because it says this was not an empyema. It was an immune effusion.
He defervesced and looked better. On the morning of day six he was stable on two litres of nasal oxygen.
Intermittent desaturation, increasing somnolence, then frank hypoxaemia. The chest film showed the left hemithorax opacified again. On a fifteen-litre reservoir mask his saturations stayed below 90 per cent and he became progressively drowsy, and he was intubated on a general paediatric ward.
He had had the identical radiographic finding two days earlier and tolerated it. That is the whole case in one observation: the film was the same and the child was not.
The CT and the bronchoscopy, done within hours of each other, found all of them.
D-dimer on the day he deteriorated was 4,591 ng/mL. Heparin went up immediately, he was extubated two days later, and the intracardiac thrombus had gone by day twelve. He moved to apixaban, went home on day sixteen, and completed three months of anticoagulation. At two months the emboli had resolved; at three months the chest film was clear.
Mycoplasma is the organism of school-age community-acquired pneumonia and is usually mild and self-limiting. The severe disease is not the organism doing more damage; it is the host response doing it. The authors set out the proposed mechanisms for the thrombosis: immune complex–mediated endothelial injury, cytokine-driven hypercoagulability, transient antiphospholipid antibodies — particularly lupus anticoagulant — and local vascular inflammation next to infected lung seeding thrombus in situ.
The same logic runs through the whole case. The effusion was immune rather than infective. The cast was epithelial injury and overproduction of mucinous and fibrinous material. The clots were an inflamed endothelium. One organism, three systems, and an immune response that overshot in all of them.
His thrombophilia screen was normal and his antiphospholipid antibodies were negative in the acute phase. Lupus anticoagulant was detected only at six weeks, with no other antiphospholipid antibodies and no recurrent thrombosis.
That is consistent with the transient, infection-associated antibody the authors describe, and it is a useful reminder in the other direction too: a positive lupus anticoagulant after an infection is not by itself a diagnosis of antiphospholipid syndrome, and testing at the wrong moment generates answers nobody knows what to do with.
It is one patient. A case report is the lowest rung of the evidence ladder and this one is reported precisely because the combination is rare. It tells you something is possible. It cannot tell you how often, in whom, or whether acting on it more widely would do more good than harm.
The recommendations outrun the design. The authors conclude that early bronchoscopy, comprehensive imaging and prompt anticoagulation are essential for optimal outcomes. That may well be right, but it is a conclusion drawn from a single favourable outcome, and one child who did well after an intervention is not evidence that the intervention caused it.
Confounders they cannot separate. He had methylprednisolone from the start, then a change of antibiotic, then drainage, then bronchoscopy, then heparin, over six days. Any of those could have mattered, and the design cannot apportion credit. The nasopharyngeal swab also grew Haemophilus influenzae, though at a cycle threshold of 40.73 — which is essentially at the limit of detection and probably means nothing.
And the setting is not ours. Macrolide resistance rates in Korea are among the highest in the world, and the threshold for early bronchoscopy differs a great deal between systems. The mechanism travels; the management pathway may not.
None of which is a reason to dismiss it. Case reports earn their place by widening the differential, and this one widens it usefully: a common, mild organism, in a well child, producing an airway catastrophe and a thromboembolic one simultaneously. You will probably never see it. You will only recognise it if you have read about it.
Be honest: on the afternoon of day six, what would you have done?
Same child, same unit, same film as two days before — and now he is drowsy on a reservoir mask. You have to decide what to look for. Tap the closest to the truth, and add what you think you would really have done.
Each tap opens a reply straight to me. If your device blocks it, write to icuandyou@icloud.com instead.